[HTML][HTML] Cost-effectiveness evaluations of the 9-Valent human papillomavirus (HPV) vaccine: Evidence from a systematic review
… implications in extending HPV immunization programs whether switching to the 9-valent
vaccine … the emphasis to include extended 2-dose HPV immunization for girls aged 9–14 years, …
vaccine … the emphasis to include extended 2-dose HPV immunization for girls aged 9–14 years, …
[HTML][HTML] The impact and cost-effectiveness of 9-valent human papillomavirus vaccine in adolescent females in Hong Kong
TH Cheung, SSY Cheng, DC Hsu, QWL Wong… - Cost Effectiveness and …, 2021 - Springer
… the impact of a school-based strategy comprising two-dose … vaccination among females
aged 13–18 years (two-dose … with analyses of other HPV vaccination programs, including those …
aged 13–18 years (two-dose … with analyses of other HPV vaccination programs, including those …
Public health impact and cost-effectiveness of catch-up 9-valent HPV vaccination of individuals through age 45 years in the United States
… -up 9-valent Human Papillomavirus (HPV) vaccination through … the 9-valent HPV vaccine
types was highest among women … persons were vaccinated with 655.8 million doses over the …
types was highest among women … persons were vaccinated with 655.8 million doses over the …
[HTML][HTML] Public health impact and cost effectiveness of routine and catch-up vaccination of girls and women with a nine-valent HPV vaccine in Japan: a model-based …
P Cody, K Tobe, M Abe, EH Elbasha - BMC Infectious Diseases, 2021 - Springer
… programs, vaccination against human papillomavirus (HPV) … women and introduce the
9-valent HPV vaccine in Japan [13]… number of doses by cost per dose gives total vaccination cost …
9-valent HPV vaccine in Japan [13]… number of doses by cost per dose gives total vaccination cost …
Public health impact and cost-effectiveness of a nine-valent gender-neutral HPV vaccination program in France
L Majed, X Bresse, N El Mouaddin, A Schmidt… - Vaccine, 2021 - Elsevier
… public health impact and cost-effectiveness of a 9-valent GNV … Human Papillomavirus (HPV)
infections can be passed on … the third dose after having received the second dose was set to …
infections can be passed on … the third dose after having received the second dose was set to …
[HTML][HTML] … the cost-effectiveness of HPV vaccination for adolescent girls in Japan: A comparison of 2-valent, 4-valent, and 9-valent HPV vaccines with consideration of …
… of the 9-valent human papillomavirus (9vHPV) vaccine in the … on the associated financial
implications and health outcomes… Among vaccination strategies, routine HPV vaccination using …
implications and health outcomes… Among vaccination strategies, routine HPV vaccination using …
[HTML][HTML] Health impact and cost-effectiveness of implementing gender-neutral vaccination with the 9-valent human papillomavirus vaccine in Belgium
S Simoens, A Bento-Abreu, B Merckx… - Frontiers in …, 2021 - frontiersin.org
… in the international trend to combat HPV-related disease with HPV vaccination. In general, …
ie, 2-dose schedule for children under 15 years and 3-dose schedule for children between 15 …
ie, 2-dose schedule for children under 15 years and 3-dose schedule for children between 15 …
[HTML][HTML] Global impact and cost-effectiveness of one-dose versus two-dose human papillomavirus vaccination schedules: a comparative modelling analysis
… We simulated routine vaccination with the 9-valent HPV vaccine in 10-year-old girls at 80% …
We calculated the difference between cervical cancer incidence predicted by PRIME and …
We calculated the difference between cervical cancer incidence predicted by PRIME and …
[HTML][HTML] … health and economic implications of adopting a 1-dose 9-valent human papillomavirus vaccination regimen in a high-income country setting: An analysis in …
V Daniels, K Saxena, O Patterson-Lomba… - Vaccine, 2022 - Elsevier
… between the vaccine parameters and the cost-effectiveness … of HPV vaccination to estimate
the impact on additional cancer … and cost-effectiveness when switching from a 2-dose HPV …
the impact on additional cancer … and cost-effectiveness when switching from a 2-dose HPV …
Effectiveness and cost-effectiveness of human papillomavirus vaccination through age 45 years in the United States
JF Laprise, HW Chesson, LE Markowitz… - Annals of internal …, 2020 - acpjournals.org
… US vaccination policy on use of the 9-valent HPV vaccine in … HPV vaccination is extended
to mid-adults with a 2-dose … The impact of human papillomavirus vaccination in the United …
to mid-adults with a 2-dose … The impact of human papillomavirus vaccination in the United …